Clinical Trial Update: QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for QUILT-3.019 indicates the Phase 1/2 study of NPC-1C monoclonal antibody for metastatic pancreatic and metastatic colorectal cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• NPC-1C (NPC-1C)

Snippet

Sponsor: Precision Biologics, Inc | Conditions: Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED